Judy Aeum

Mar 14, 2024 | jamanetwork.com | James Bailey |Benjamin Kuhar |Judy Aeum

Pembrolizumab and other immune checkpoint inhibitors are an effective alternative to traditional chemotherapy in sensitizing the immune system to combat cancer cells.1 While effective against malignancies, this mechanism of action can lead to immune-related complications.2 We present a case of conjunctival ulceration following pembrolizumab therapy for breast cancer.